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Abstract
Urosepsis is a bacteraemia infection caused by an organism previously causing an infection in the urinary tract of a patient, a diagnosis which
has been classically confirmed by culture of the same species of bacteria from both blood and urine samples. Given the new insights afforded
by sequencing technologies into the complicated population structures of infectious agents affecting humans, we sought to investigate
urosepsis by comparing the genome sequences of blood and urine isolates of Escherichia coli from five patients with urosepsis. The results
confirm the classical urosepsis hypothesis in four of the five cases, but also show the complex nature of extra-intestinal E. coli infection in
the fifth case, where three distinct strains caused two distinct infections. Additionally, we show there is little to no variation in the bacterial
genome as it progressed from urine to blood, and also present a minimal set of virulence genes required for bacteraemia in E. coli based on
gene association. These suggest that most E. coli have the genetic propensity to cause bacteraemia.
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Abstract
Amoxicillin is a first-line antibiotic treatment for acute otitis media in children and one of the most commonly used antibiotics for human
bacterial infections. We investigated changes in salivary bacterial communities among children treated with amoxicillin for acute otitis media
(n = 18), using a culture-independent approach based on pyrosequencing of the V3 region of the bacterial 16S rRNA gene. The control
group consisted of children with acute otitis media who were not given antibiotics (n = 15). One species-level phylotype assigned to the
genus Streptococcus was identified across all (n = 99) saliva samples. Two additional species-level phylotypes from the genera Gemella and
Granulicatella were shared by all (n = 45) samples of control subjects. Amoxicillin treatment resulted in reduced species richness and
diversity, and a significant shift in the relative abundance of 35 taxa at different ranks from phylum to species-level phylotype. At the phylum
level, prevalence of TM7 and Actinobacteria decreased at the end of treatment, whereas Proteobacteria had a higher relative abundance
post-treatment. Multivariate analysis showed that samples from the same control subject taken over time intervals tended to cluster
together. Among antibiotic-treated subjects, samples taken before and at the end of amoxicillin treatment formed two relatively
well-separated clusters both of which greatly overlapped with samples taken about 3 weeks post-treatment. Our results point to a
substantial but incomplete recovery of the salivary bacterial community from the antibiotic about 3 weeks after the end of treatment.
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